Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial

Nadinda A.M. Van Der Ende*, Bob Roozenbeek, DUMAS Investigators, Lucas E.M. Smagge, Sven P.R. Luijten, Leo A.M. Aerden, Petra Kraayeveld, Ido R. Van Den Wijngaard, Geert J. Lycklama À Nijeholt, Heleen M. Den Hertog, H. Zwenneke Flach, Alida A. Postma, Stefan D. Roosendaal, G. Menno Krietemeijer, Lonneke S.F. Yo, Moniek P.M. De Maat, Daan Nieboer, Gregory J. Del Zoppo, William J. Meurer, Hester F. LingsmaAad Van Der Lugt, Diederik W.J. Dippel

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
18 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science